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Wen-Chieh Yang1, Lu-Lu Zhao2, Chun-Yu Chen1, Yung-Kang Wu3, Yu-Jun Chang4 and Han-Ping Wu5,6*Background: Hypertensive crisis in children is a relatively rare condition presenting with elevated blood pressure
(BP) and related symptoms, and it is potentially life-threatening. The aim of this study was to survey children with
first attacks of hypertensive crisis arriving at the emergency department (ED), and to determine the related
parameters that predicted the severity of hypertensive crisis in children by age group.
Methods: This was a retrospective study conducted from 2000 to 2007 in pediatric patients aged 18 years and
younger with a diagnosis of hypertensive crisis at the ED. All patients were divided into four age groups (infants,
preschool age, elementary school age, and adolescents), and two severity groups (hypertensive urgency and
hypertensive emergency). BP levels, etiology, severity, and clinical manifestations were analyzed by age group and
compared between the hypertensive emergency and hypertensive urgency groups.
Results: The mean systolic/diastolic BP in the hypertensive crisis patients was 161/102 mmHg. The major causes of
hypertensive crisis were essential hypertension, renal disorders and endocrine/metabolic disorders. Half of all
patients had a single underlying cause, and 8 had a combination of underlying causes. Headache was the most
common symptom (54.5%), followed by dizziness (45.5%), nausea/vomiting (36.4%) and chest pain (29.1%). A family
history of hypertension was a significant predictive factor for the older patients with hypertensive crisis. Clinical
manifestations and severity showed a positive correlation with age. In contrast to diastolic BP, systolic BP showed a
significant trend in the older children.
Conclusions: Primary clinicians should pay attention to the pediatric patients who present with elevated blood
pressure and related clinical hypertensive symptoms, especially headache, nausea/vomiting, and altered
consciousness which may indicate that appropriate and immediate antihypertensive medications are necessary to
prevent further damage.
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It has been demonstrated that high blood pressure (BP)
contributes to the early development of cardiovascular
structural and functional changes in children [1,2]. With
increasingly high BP, autoregulation eventually fails,
leading to damage of the vascular wall and further organ
hypoperfusion. Hypertensive crisis is a critical condition
characterized by a rapid, inappropriate and symptomatic
elevated BP, and is categorized as hypertensive urgency
(without damage of target-organs) and hypertensive
emergency, which is associated with rapid deterioration* Correspondence: arthur1226@gmail.com
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is a potentially life-threatening condition. Hypertensive
encephalopathy, an example of hypertensive emergency,
is associated with hypertension (HTN) and includes a
combination of various neurological manifestations such
as altered mental status, headache, nausea, vomiting, vis-
ual disturbance, seizure (76% of patients exhibit three of
these four signs), or even stroke [3-7].
The causes of HTN and hypertensive crisis vary by
age. Primary HTN accounts for most hypertensive
children over the age of six years, and 90% of the causes
of HTN in children over 15 years of age [8-11]. Younger
and more severe HTN pediatric patients are believed to
account for secondary HTN. As a result of increasing
mean BMI levels and increasing salt intake, the
incidence of HTN in children appears to be steadilyd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reported to range from 1% to 5% of children aged 1 to
18 years in the United States [1,2,10]. In Taiwan, HTN
has been found to range from 0.13% to 0.5% of children
aged 6 to 15 years, and around 1% to 3% of school-aged
children [13,14]. The objective of this study was to
analyze the clinical features, etiology and treatment of
children with first attacks of hypertensive crisis and to




From January 2000 to January 2008, we conducted this
retrospective chart review of all patients 18 years and
under with a diagnosis of HTN in our pediatric ED of
Changhua Christian Hospital, a 2500-bed medical center
in central Taiwan. The exclusion criteria were as follows:
a BP below the 95th percentile, a final diagnosis of tran-
sient hypertension, asymptomatic hypertensive patients,
and those with incomplete data including inadequate
body height or weight data, and no repeated BP mea-
surements. A total of 112 patients presented to our
pediatric ED with the diagnosis of primary and second-
ary hypertension. Sixteen patients were excluded for
having a BP less than the 95th percentile, 28 were
excluded for asymptomatic hypertension, 10 were
excluded due to a final diagnosis of transient hyperten-
sion, and three were excluded due to inadequate data.
Therefore, the study group comprised 55 patients with
hypertensive crisis. The study was approved by the
Human Subjects Review Committee of the hospital.
The patients were divided into four age groups: infants
(less than one year of age); preschool age (one to six
years of age); elementary school age (seven to 12 years
of age); and adolescents (13 to 18 years of age). Patients
with hypertensive crisis were further subcategorized into
two severity groups: hypertensive urgency and hyperten-
sive emergency. Severity was based on the presence of
end organ damage. Staging of HTN was defined as a BP
between the 95th percentile and 99th percentile plus
5 mmHg (stage 1) and above the 99th percentile plus
5 mmHg (stage 2).
Blood pressure measurements
All children above three years of age received initial BP
measurements at our pediatric ED when triaging. With
the exception of children who were bedridden and
infants who were unable to sit, BP was checked with the
children in a seated position with their backs supported,
feet on the floor, right arm supported, and with the cu-
bital fossa at heart level. An appropriate cuff size was
used with an inflatable bladder width that was at least
40% of the arm circumference at a point midwaybetween the olecranon and the acromion. The cuff blad-
der length covered 80 to 100% of the circumference of
the arm. Initially, aneroid manometers (automatic
devices) were used to measure BP with an appropriate
cuff. If the systolic BP (SBP) or diastolic BP (DBP) was
higher than 120/80 mmHg, it was re-measured from
both hands and legs [15]. BP measurements were per-
formed every hour in the patients who presented with
an unstable BP and in the patients requiring further ob-
servation. During the study period, the BP measure-
ments were performed by different nurses, all of whom
were well-trained and qualified.
Identification of hypertension
HTN in children more than 12 months of age was
defined according to BP standards based on gender, age
and height as stipulated in the updated classification of
hypertension by the National Blood Pressure Education
Program Working Group on Hypertension in Children
and Adolescents [7]. HTN was identified when the SBP
or DBP was greater than or equal to the 95th percentile;
stage 1 HTN was defined as an SBP or DBP within the
range of the 95th percentile to the 99th percentile plus
5 mmHg; stage 2 HTN was an SBP or DBP greater than
the 99th percentile plus 5 mmHg. For the patients
younger than 12 months of age, hypertension was
defined as an SBP or DBP greater than the 95th percent-
ile for infants of a similar age, size and sex according to
a previously published report [16]. When systolic and
diastolic percentiles differed, they were categorized
according to the higher value. Transient HTN means
transient blood pressure elevation caused by any emo-
tional, painful, or uncomfortable events, and was defined
as an asymptomatic BP higher than the 95th percentile
only once or twice, but returning to less than the 95th
percentile on the second or third measurement without
any antihypertensive medication [5].
A hypertensive emergency was defined as HTN in the
presence of acute or ongoing target-organ lesions, or
HTN in relation to an immediate life-threatening event re-
quiring immediate intervention to reduce the BP [9,11,13].
Hypertensive urgency was defined as an elevation in SBP/
DBP higher than the 99th percentile plus 5 mmHg with
any complication related to the HTN and no evidence of
target-organ lesions. End organ damage was defined as
impairment in renal, myocardial, hepatic, and hematologic
functions, and neurological manifestations derived from
HTN. Acute (transient) end organ damage resulting from
HTN was identified by abnormal clinical and laboratory
findings which subsided after a decrease in BP. Abnormal
data included abnormal electrocardiography findings,
impaired renal function tests, elevated liver function mar-
kers, and neurological manifestations such as headache,
altered consciousness and dizziness.
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drome characterized by acute neurological change in the
setting of sudden and/or prolonged HTN that overcomes
the autoregulatory capacity of the cerebral vasculature
[17,18]. The syndrome is defined as severe hypertension in
conjunction with symptoms of headache, altered mental
status, seizure, or visual disturbances, and commonly pre-
sents with reversible posterior leukoencephalopathy seen
on T2-weighted brain magnetic resonance images [19-22].
Methods of analysis
The following data were collected and analyzed: age,
gender, weight, height, family history of HTN, BP on arrival
to the ED, clinical manifestations of hypertensive crisis
(dizziness, headache, nausea/vomiting, visual symptoms,
seizure/type, altered consciousness, chest tightness/pain,
target-organ damage), reversibility, anti-hypertension drugs,
underlying causes (renal disease, cardiovascular (CV),
essential HTN, central nervous system (CNS) factors, endo-
crine/metabolic disorders, oncological disease), recurrent
episodes, brain imaging and duration of hospitalization
(ward/intensive care unit (ICU)). In addition, to decrease
the influence of age, exact BMI percentile and z-score
(standard deviation score), and SBP/DBP z-score according
to the Center for Disease Control (CDC) growth charts
were also analyzed.
CNS factors referred to CNS abnormalities as the
cause of hypertension, which is different from hyperten-
sive encephalopathy in causal connection. Essential
hypertension was diagnosed after excluding secondary
causes of hypertension by multiple tests, such as electro-
cardiography, metabolic panel, renal function tests,
hemoglobin and urine routine tests, or other further
specific tests including echocardiography, renal ultra-
sound, plasma rennin activity, plasma aldosterone,
thyroid-stimulating hormone and 24-hour urine free
cortisol.Figure 1 Ratios of clinical manifestations in the pediatric patients witCase distributions of hypertensive emergency and ur-
gency were surveyed based on different time periods.
During the study period, the BP levels, etiology, severity,
and clinical manifestations were compared among chil-
dren by age group and compared between the patients
with hypertensive emergency and hypertensive urgency.
Statistical analysis
All statistical analyses were performed using Fisher’s
exact test, the Kruskal Wallis test, Jonckheere Terpstra
test, and chi-square test as appropriate. The results of
the descriptive analyses of independent variables were
reported as percentages and mean ± S.D. A P value less
than 0.05 was considered statistically significant. Statistical
analyses were performed using SPSS software (version
15.0; SPSS Inc., Chicago, IL, USA).
Results
Characteristics of the study subjects
From 2000 to 2007 55 children presented to the ED with
hypertensive crisis, including 46 cases (83.6%) with
hypertensive urgency and 9 cases (16.4%) with hyperten-
sive emergency (incidence ratio 5:1). Five children had a
diagnosis of hypertensive encephalopathy. The male-to-
female incidence ratio was 5:1 (boys, n = 46; girls, n = 9).
Most patients were in the adolescent group (n = 24,
43.6%). A family history of hypertension was only noted
in the patients older than preschool age (n = 8, 14.5%).
Almost all of the pediatric hypertensive crisis patients
presented with hypertension stage 2 (n = 54, 98.1%). The
major symptoms of hypertensive crisis were headache
(n = 30, 54.5%), followed by dizziness (n = 25, 45.5%),
and nausea/vomiting (n = 20, 36.4%) (Figure 1). The
leading underlying causes were essential hypertension
(n = 26, 47.2%), followed by renal disease, and endo-
crine/metabolic disease. The renal diseases included
nephrotic syndrome (n = 2, 14.3%), IgA nephropathyh hypertensive crisis.
Table 1 Characteristics of the patients with hypertensive crisis by age group
Age (years)
<1 (n = 7) 1–6 (n = 5) 7–12 (n = 19) 13–18 (n = 24)
Variables N % N % N % N % P-value1 P-value2
Gender
Female 0 0.0 3 60.0 4 21.1 2 8.3 0.037 0.517
Male 7 100.0 2 40.0 15 78.9 22 91.7
Family history 0 0.0 0 0.0 2 10.5 6 25.0 0.362 0.049
Blood Pressure
SBP > 99th percentile +5 7 100.0 4 80.0 19 100.0 24 100.0 0.091 0.282
DBP > 99th percentile +5 6 85.7 3 60.0 14 73.7 19 79.2 0.779 0.955
Stage of hypertension
Stage 1 0 0.0 1 20.0 0 0.0 0 0.0 0.108 0.313
Stage 2 7 100.0 4 80.0 19 100.0 24 100.0
Clinical presentations
Altered Consciousness 2 28.6 2 40.0 2 10.5 3 12.5 0.068 0.372
Headache 0 0.0 3 60.0 13 68.4 14 58.3 0.085 0.054
Nausea/Vomiting 2 28.6 2 40.0 8 42.1 8 33.3 0.922 0.960
Visual symptoms 0 0.0 0 0.0 0 0.0 2 8.3 0.693 0.201
Seizure 1 14.3 2 40.0 1 5.3 2 8.3 0.142 0.282
Dizzy 2 28.6 0 0.0 11 57.9 12 50.0 0.094 0.130
Chest pain 0 0.0 1 20.0 8 42.1 7 29.2 0.195 0.187
End-organ damage 2 28.6 2 40.0 3 15.8 2 8.3 0.178 0.086
Reversibility 3 42.9 3 60.0 9 47.4 13 54.2 0.931 0.701
Anti-HTN drugs 2 28.6 2 40.0 10 52.6 16 66.7 0.285 0.054
Etiology
Essential HTN 0 0.0 1 20.0 8 42.1 15 62.5 0.008 0.001
Renal disease 3 42.9 1 20.0 6 31.6 4 16.7 0.423 0.166
CNS 2 28.6 1 20.0 0 0.0 1 4.1 0.202 0.120
Endocrine/metabolic 1 14.3 1 20.0 3 15.8 4 16.7 0.952 0.358
CV 1 14.3 0 0.0 1 5.3 0 0.0 0.252 0.117
Oncology 0 0.0 1 25.0 1 5.3 0 0.0 0.092 0.389
Recurrent episode 4 57.1 1 20.0 5 26.3 6 25.0 0.440 0.196
Severity
Urgency 5 71.4 3 60.0 16 84.2 22 91.7 0.178 0.086
Emergency 2 28.6 2 40.0 3 15.8 2 8.3
Hospitalization
Ward 3 42.9 4 80.0 8 42.1 9 37.5 0.425 0.398
ICU 0 0.0 1 20.0 3 15.8 3 12.5 0.271 0.886
POU 4 57.1 0 0.0 8 42.1 12 50.0 1.000 0.565
1by Fisher’s exact test.
2by the chi-square test for trend.
SBP: systolic blood pressure; DBP: diastolic blood pressure; HTN: hypertension; CNS: central nervous systems; CV: cardio-vascular; ICU: intensive care unit; POU:
pediatric observation unit.
Yang et al. BMC Pediatrics 2012, 12:200 Page 4 of 8
http://www.biomedcentral.com/1471-2431/12/200
Yang et al. BMC Pediatrics 2012, 12:200 Page 5 of 8
http://www.biomedcentral.com/1471-2431/12/200(n = 2, 14.3%), poststreptococcal glomerulonephritis
(n = 1, 7.1%), end stage renal disease (ESRD), Henoch-
Schönlein purpura with glomerulonephritis (n = 1, 7.1%),
ureteropelvic junction obstruction (n = 1, 7.1%), Alport
syndrome with ESRD (n = 1, 7.1%), focal segmental
glomerulosclerosis with ESRD (n = 1, 7.1%), polycystic
kidney (n = 1, 7.1%), Alstrom syndrome with chronic
renal insufficiency (n = 1, 7.1%), inborn error, hyperam-
monemia with ESRD (n = 1, 7.1%), ESRD s/p renal
transplantation (n = 1, 7.1%), and SLE with lupus
glomerulonephritis (n = 1, 7.1%). The endocrine and
metabolic diseases included hyperthyroidism (n = 3,
33.3%), diabetes mellitus (n = 3, 33.3%), hyperaldosteron-
ism (n = 1, 11.1%), adrenal hyperplasia (n = 1, 11.1%),
and methylmalonic academia with hyperuricemia (n = 1,
11.1%). The oncological disorders included pheochromo-
cytoma associated with neurofibromatosis (n = 1, 50%)
and paraganglioneuroma (n = 1, 50%). The recurrence
rate of hypertensive crisis was 29.1% (16 cases: 12 ur-
gency; 4 emergency) during the study period. A total of
33 (60%) patients who visited the ED were hospitalized:
24 to wards, 7 to the pediatric intensive care unit
(PICU), and 2 to the pediatric observation unit (POU) of
the pediatric ED.
Hypertensive crisis by age group
Boys had a higher morbidity of hypertensive crisis in
every age group except for the infant group (Table 1). A
positive family history was present only in the children
older than 7 years: 2 (10.5%) in the school age group,
and 6 (25%) in the adolescent group. About half of the
patients had underlying causes (n = 27, 49%). EssentialTable 2 Description of results obtained in various age catego
and blood pressure
Age 1–6 (n = 3)a 7–12 (n = 13)b
Mean ± SD Mean ± SD
BW 27.67 ± 20.43 53.35 ± 28.19
Height 103.00 ± 15.72 144.66 ± 10.38
Height Z-Score −8.85 ± 2.91 −3.43 ± 1.15
BMI 24.30 ± 12.95 24.88 ± 12.60
BMI Z-score 1.52 ± 1.68 1.13 ± 1.49
BMI Percentile 81.33 ± 20.74 75.54 ± 31.11
SBP 189.67 ± 36.91 158.38 ± 25.09
DBP 136.00 ± 38.16 93.54 ± 19.98
Expected SBP 103.80 ± 16.23 95.17 ± 4.12
Expected DBP 76.78 ± 22.76 54.46 ± 3.42
SBP Z-score 8.10 ± 4.15 5.93 ± 2.34
DBP Z-score 5.22 ± 5.26 3.41 ± 1.74
a,b,c: the mean data of each age group.
P-value by one-way analysis of variance followed by Sidak multiple comparisons at
SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index.HTN was also diagnosed in approximately half of the
patients (n = 26, 47.3%). Among the underlying causes,
essential HTN had a significant correlation with age
(Table 1). The z-scores of BMI and SBP/DBP in the chil-
dren by age group are listed in Table 2. The mean BMI
values of the children with hypertensive crisis were all
above the threshold of obesity. The mean SBP/DBP in
the patients with hypertensive crisis was 161/102 mmHg.
In contrast to DBP, SBP had a significant trend with
older age. The patients with hypertensive crisis received
antihypertensive agents, and the BP levels gradually
decreased by about 25% to 30% within one hour, finally
returning to normal ranges about two to three days later
during hospitalization.
Patients with hypertensive encephalopathy
Five male patients, all without a family history of hyper-
tension, had hypertensive encephalopathy at the ages of
5, 9, 12, 13 and 14 years, respectively (Table 3). Their
presenting BP levels at the ED were all classified as stage
2 hypertension, and four of them had a DBP and SBP
above the 99th percentile plus 5 mmHg, ranging from
148 to 231 mmHg of systolic BP, and 86 to 172 mmHg
of diastolic BP. All had altered consciousness; three were
in a coma on arrival and recovered after their BP had
been controlled. The major associated symptoms were
headache and nausea/vomiting. Oncological causes were
the major factors in the patients with hypertensive en-
cephalopathy, one being induced by pheochromocytoma
and one by paraganglioneuroma. Two of the patients
with hypertensive encephalopathy had recurrent hyper-
tensive crisis episodes during the study period. Magneticries of hypertensive crisis patients in characteristics, BMI
13–18 (n = 18)c P-value Post hoc tests
Mean ± SD
83.64 ± 33.27 0.005 a,b < c
167.95 ± 9.58 <0.001 a < b < c
−0.70 ± 1.24 <0.001 a < b < c
29.05 ± 9.08 0.522
3.07 ± 6.96 0.587
84.56 ± 25.93 0.675
164.22 ± 23.84 0.174
104.61 ± 19.03 0.013 a > b
109.91 ± 5.11 <0.001 b < c
62.32 ± 3.76 <0.001 a > c > b
5.08 ± 2.17 0.135
3.68 ± 1.75 0.432
a type I error of 0.05.
Table 3 The characteristics of the patients with hypertensive encephalopathy (N = 5)
Case 1 Case 2 Case 3 Case 4 Case 5
Gender (F/M) M M M M M
Age (year) 9 12 13 5 14
Weight (kg) 24 39 68 19 35
Height (cm) 134 158 110
Family history no no no no no
Arrival BP 166/130 176/86 220/128 231/172 148/109
Hypertension stage stage 2 stage 2 stage 2 stage 2 stage 2
SBP > 99th percentile + 5 33(25.3%) 42
(31.4%)
82(59.4%) 106(84.8%) 3(2%)
DBP > 99th percentile + 5 38(41.3%) 34(36.1%) 86(101%) 12(11%)
clinical manifestations
Consciousness change Coma Coma Coma Drowsy Disturbance
Headache + 0 + + +
Nausea/Vomiting 0 0 + + +
Visual symptoms 0 0 + 0 0
Seizure 0 0 0 + +
Dizzy 0 0 0 0 +
Chest tightness 0 0 0 0 0









Recurrent episode (times) 0 0 0 3 >5
CSF data 0 0 0 0 normal
EEG finding 0 0 normal 0 normal
Hospitalization duration (days)
(ward/ICU/POU)
9(4/5/0) 11(5/6/0) 5(3/2/0) 7(7/0/0) 6(6/0/0)
SBP: systolic blood pressure; DBP: diastolic blood pressure; HTN: hypertension; CSF: cerebrospinal fluid; EEG: Electroencephalography; ICU: intensive care unit; POU:
pediatric observation unit.
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signal intensity in the subcortical white matter and cor-
tical gray matter of the parieto-occipital area, cerebellum
and basal ganglia. Magnetic resonance spectrometry
(MRS) showed a high lactate peak with normal N-acetyl
aspartate (NAA), choline and creatine levels (Table 3).
Case distribution analysis and treatment
The year and month distribution analysis of hypertensive
urgency and emergency is shown in Figure 2. The analysis
revealed that the prevalence of children with hypertensive
crisis in the total number of children who came to the ED
increased by year during the study period. The distribution
by month revealed that hypertensive emergency occurred
mostly in the spring (March to June).
During the study period, there were no cases of mortality
or sequelae. Nine patients received multi-antihypertensive
agents. Long-term-acting amlodipine besylate was used in
seven patients; atenolol in nine patients; captopril in sixpatients; nifedipine in four patients; carvedilol, inderol and
labetalol were used separately in three cases; and pentoxi-
fylline, servidipine, lisinopril, and nicametate were each
used once. None of the patients received antihypertensive
medication before arriving at the pediatric ED.
Discussion
In comparison to adults, hypertensive crisis in children
is a relatively rare condition. It presents with elevated
BP and related symptoms and is potentially life-threaten-
ing. In clinical practice, high BP is often treated as an
associated symptom rather than a specific complaint.
However, the importance of pediatric hypertension is
easily underestimated without understanding the dam-
age caused by high BP.
For the pediatric patients with hypertensive crisis in
our study, as their age increased, more related family
histories of HTN and more essential hypertensive causes
were noted. After seven years of age, essential HTN
Figure 2 Distribution of hypertensive crisis in the children from 2000 to 2008 by year (A), and month (B).
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sis, whereas before the age of seven, hypertensive crisis
was mostly attributed to secondary HTN. However, even
though secondary hypertension was the major cause for
the younger patients, there was no statistical correlation
between age and different underlying causes of pediatric
hypertensive crisis. Renal diseases were the major under-
lying cause of first-attack hypertensive crisis, and they
could induce a first attack of hypertensive crisis at any
age. Catecholamine producing tumors, such as pheo-
chromocytoma and paraganglioneuroma induced higher
blood pressure, resulting in the highest BP and most se-
vere clinical outcomes, and were able to induce first-
attacks of hypertensive emergency and even hypertensive
encephalopathy at any age.
Almost all of the patients in this study presented with
BP levels higher than the 99th percentile plus 5 mmHg
(stage 2 HTN). Therefore, the 99th percentile plus
5 mmHg may serve as a critical threshold for a high risk
of hypertensive crisis in children. Some studies have also
suggested that stage 2 hypertension requires prompt
evaluation and treatment once the stage of HTN is per-
sistent [1,6]. Moreover, symptoms such as headache and
nausea/vomiting associated with a BP level above the
99th percentile plus 5 mmHg should be regarded aswarning signs of the end organ damage and secondary
hypertension. Other reported related symptoms of HTN
in children include blurred vision, and disease-specific
symptoms such as edema, pallor and petechiae [23]. In
addition, although the patients with hypertensive emer-
gency in the current study did not have any sequelae,
permanent neurological damage, blindness, and chronic
renal failure have been reported to be long-term conse-
quences of hypertensive emergency [24].
There are some limitations to our study. First, due to
the relatively low incidence of hypertensive crisis, only
55 patients were identified over the eight-year period of
this study. The small sample size and the selection of
participants from a single medical center limit the
generalizability of our results to the entire population of
patients with hypertensive crisis. Second, family histories
and physical examination findings are not easily identifi-
able in a retrospective study, and this may have led to
missing data in the analysis. These limitations may have
led to bias in analyzing the first attacks of hypertensive cri-
sis in the ED.
Conclusions
In conclusion, ED physicians should pay attention to all
pediatric patients who present with an elevated BP and
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and altered consciousness. Once patients have a BP level
higher than stage 2 hypertension, appropriate and imme-
diate antihypertensive medications are necessary to pre-
vent further damage.
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